Angiogenesis and angiogenic growth factors in Wilms tumor

Journal of Urology

Volumn 165, Issue 6 II SUPPL., 2001, Pages 2274-2279

  Skoldenberg E G ^a   Christiansson, J ^a   Sandstedt, B ^a   Larsson, A ^a   Lackgren G ^a   Christofferson, R ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Sweden)

Author keywords

Angiogenesis factor; Kidney neoplasms; Neovascularization; Nephroblastoma; Pathologic; Prognosis

Indexed keywords

ANGIOGENIC FACTOR; ANGIOGENIN; BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; EPIDERMAL GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; CANCER GROWTH; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MALE; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); NEPHROBLASTOMA; NEWBORN; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0035022624     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)66183-6     Document Type: Conference Paper

References (30)

1. Clinical applications of research on angiogenesis
2. Antiangiogenic therapy
3. Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis
4. Tumor angiogenesis as a prognostic predictor in colorectal carcinoma with special reference to mode of metastasis and recurrence
5. Results of the United Kingdom children's cancer study group first Wilms' tumor study
6. Results of the 6th international society of pediatric oncology Wilms' tumor trial and study: A risk-adapted therapeutic approach in Wilms' tumor
7. Tumor angiogenesis and metastasiscorrelation in invasive breast carcinoma
8. Novel methods for the determination of the angiogenic activity of human tumors
9. Angiogenesis in breast cancer: A comparative study of the observer variability of methods for determining microvessel density
10. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor
11. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients
12. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
13. Aminoalkylsilane-treated glass slides as support for in situ hybridization of keratin cDNAs to frozen tissue sections under varying fixation and pretreatment conditions
14. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
15. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma
16. Histological analysis of aggressiveness and responsiveness in Wilms' tumor
17. New definitions of focal and diffuse anaplasia in Wilms tumor: The international society of paediatric oncology (SIOP) experience
18. Distribution of subtypes in standard Wilms' tumor after pre-operative chemotherapy and its possible influence on the patients' cure rate
19. Pretreatment, ultrasound-guided cutting needle biopsies in childhood renal tumors
20. The physiology of transforming growth factor-alpha
21. Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma: The nordic myeloma study group
22. Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients
23. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
24. Tumour angiogenesis factor (TAF) in human and animal tumours
25. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
26. Tumor angiogenesis: Therapeutic implications
27. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
28. Antiangiogenic activity of the cleaved conformation of the serpin anti-thrombin
29. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor
30. The new SIOP (Stockholm) working classification of renal tumours of childhood